# US President Donald Trump announced new agreements aimed at lowering prescription drug prices.

*biotech · news · 2025-12-19 · Al Jazeera*

## Key points

- Pharma giants agreed to match US drug prices to the lowest among developed nations starting next year.
- Merck will offer Januvia, Janumet, Janumet XR at 70 percent off list prices directly to consumers.
- Amgen will expand direct-to-patient sales of Aimovig and Amjevita at $299 a month, deeply discounted.
- Participating drugmakers will remit a portion of foreign sales revenues to the US to offset costs.
- The companies pledged over $150 billion investment in US R&D and manufacturing alongside ingredient donations.

**Companies:** Bristol Myers Squibb, Gilead Sciences, Merck, Amgen, Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk, Regeneron, Johnson & Johnson, AbbVie
**Countries:** United States

[Read the full story on Al Jazeera](https://www.aljazeera.com/economy/2025/12/19/trump-announces-new-deal-with-pharma-companies-to-cut-drug-prices)

---

Canonical: https://newsio.io/n/c818f101-cabb-42b7-b0f2-eb270259c4f3/us-president-donald-trump-announced-new-agreements-aimed-at-lowering-prescriptio
Summarized by Newsio from Al Jazeera. https://newsio.io/how-it-works